Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846681B2 · kind B2 · utility
10Cited by
30References
91Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 14, 2011 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Jan 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.